Truepoint Inc. Has $21.28 Million Stock Position in The Procter & Gamble Company (NYSE:PG)

Truepoint Inc. grew its position in shares of The Procter & Gamble Company (NYSE:PG) by 3.8% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 122,878 shares of the company’s stock after acquiring an additional 4,516 shares during the quarter. Procter & Gamble accounts for 0.6% of Truepoint Inc.’s holdings, making the stock its 23rd biggest position. Truepoint Inc.’s holdings in Procter & Gamble were worth $21,283,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the company. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble in the 2nd quarter valued at approximately $28,000. Fairway Wealth LLC acquired a new stake in Procter & Gamble during the 2nd quarter valued at $29,000. POM Investment Strategies LLC acquired a new stake in Procter & Gamble during the 2nd quarter valued at $34,000. Quest Partners LLC acquired a new stake in Procter & Gamble during the 2nd quarter valued at $36,000. Finally, Fairfield Financial Advisors LTD acquired a new stake in Procter & Gamble during the 2nd quarter valued at $44,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

NYSE:PG opened at $176.28 on Friday. The stock’s 50-day simple moving average is $170.04 and its 200 day simple moving average is $168.64. The firm has a market capitalization of $415.15 billion, a PE ratio of 30.39, a price-to-earnings-growth ratio of 3.74 and a beta of 0.42. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a twelve month low of $142.50 and a twelve month high of $177.94.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. Procter & Gamble’s revenue was down .6% compared to the same quarter last year. During the same period last year, the firm posted $1.83 earnings per share. On average, analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s payout ratio is 69.48%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on PG. DA Davidson reaffirmed a “neutral” rating and set a $160.00 price target on shares of Procter & Gamble in a report on Wednesday. Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a report on Monday, September 30th. Dbs Bank downgraded Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. JPMorgan Chase & Co. increased their price objective on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Finally, Wolfe Research upgraded Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. Nine equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $178.00.

Insider Activity

In other news, CFO Andre Schulten sold 13,041 shares of Procter & Gamble stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the sale, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. This trade represents a 25.95 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total value of $2,163,072.00. Following the sale, the insider now directly owns 11,566 shares in the company, valued at $1,954,538.34. The trade was a 52.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 160,693 shares of company stock valued at $27,311,345. 0.18% of the stock is currently owned by corporate insiders.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.